SCHEMBL6424766

SCHEMBL6424766

CCCCCCCCCCCCCC=CC([O])=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 3/20 0.57
PPARG P37231 4/20 0.56
PPARA Q07869 4/20 0.56
TERT O14746 3/20 0.55
PTPN1 P18031 3/20 0.55
CYP1A2 P05177 2/20 0.55
MAPT P10636 2/20 0.55
CYP2C19 P33261 2/20 0.55
BLM P54132 2/20 0.55
HSD17B10 Q99714 2/20 0.55
FABP4 P15090 2/20 0.55
FAAH O00519 2/20 0.55
KMT2A Q03164 2/20 0.55
PPARD Q03181 2/20 0.55
GMNN O75496 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
POLB P06746 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7552771 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL6424763 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL4200342 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL7552935 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL5066940 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL4200339 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL502000 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL4203778 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL501714 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1
SCHEMBL7781593 1.00 FABP3 (0.57) FABP3PPARGPPARATERTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220160617-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2022-05-26 US disclosed
US-20210386802-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2021-12-16 US disclosed
EP-1551370-A1 AGGREGATE WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN IDEA AG (DE) 2005-07-13 EP disclosed
WO-2004032900-A1 AGGREGATE WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN IDEA AG (DE) 2004-04-22 WO disclosed
WO-1992003122-A1 PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS CEVC GREGOR (DE) 1992-03-05 WO disclosed
EP-0319316-A2 Griseolic acid monoesters, their preparation and use SANKYO COMPANY LIMITED (JP) 1989-06-07 EP disclosed